Neoventa Medical
Neoventa Medical is a Swedish medical device company that develops fetal monitoring systems combining cardiotocography (CTG) with proprietary ST analysis of fetal ECG, founded in 1997. It sells Stan S41 monitors, Goldtrace electrodes, ST analysis software, and clinician training to hospitals across Europe, the Middle East, Africa, and Asia-Pacific.
- Company typePrivate
- Founded1997
- HeadquartersMölndal, Sweden
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Neoventa Medical does
Neoventa Medical AB is a privately held Swedish medical device company founded in 1997 and headquartered in Mölndal, with wholly owned subsidiaries in the United Kingdom (Cobham) and France (Paris). The company develops and sells fetal monitoring systems for intrapartum obstetric care, centered on the STAN methodology — a proprietary approach that combines standard cardiotocography (CTG) with ST segment analysis of the fetal ECG waveform to detect signs of fetal hypoxia during labor. Its core product platform is the Stan S41 maternal and fetal monitor, a compact touchscreen device with optional ST analysis capability, wireless waterproof transducers, and flexible mounting options. Supporting products include the Goldtrace gold-plated fetal spiral electrode (disposable and reusable), the ST Analysis License (a software license activation that unlocks ST analysis on the Stan S41 from gestation week 36+0), and Stan Viewer desktop software for reviewing, printing, and securely sharing CTG traces and ST registrations.
The company's underlying technology — ST analysis of fetal ECG — is grounded in 50+ years of research originating with Prof KG Rosén at the University of Gothenburg in 1971. The technology is delivered alongside validated integrations with 12+ central monitoring systems (Philips IntelliSpace Perinatal, Cerner FetaLink, K2 Guardian, Huntleigh, Medexa, NEXUS/ASTRAIA, ChipSoft, Speculum), enabling ST data to flow into hospital obstetric IT platforms.
Neoventa makes money through three streams: hardware sales (Stan S41 monitors, Goldtrace electrodes, transducers, mounting solutions, and accessories), software licensing (ST Analysis License activations), and education and training services (Neoventa Academy masterclasses priced €190–€430 per participant, e-learning certifications, online patient case reviews). Go-to-market is hybrid: direct sales and support in Sweden, UK, and France, plus a network of 25+ distributors across Europe, the Middle East, Asia-Pacific, and Africa (with the November 2023 addition of South Africa via YMS Medical Supplies). The customer base consists of hospitals and maternity wards; named primary segments are labor ward heads/hospital management and obstetricians and midwives. With approximately 30 employees total, the company operates under full medical device regulatory compliance (ISO 13485, MDR 2017/745, MDSAP, CE Mark with Notified Body 2862).
Neoventa Medical firmographics
Firmographics- Name
- Neoventa Medical
- Legal name
- Neoventa Medical AB
- Website
- https://neoventa.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Neoventa Medical is a Swedish medical device company that develops fetal monitoring systems combining cardiotocography (CTG) with proprietary ST analysis of fetal ECG, founded in 1997. It sells Stan S41 monitors, Goldtrace electrodes, ST analysis software, and clinician training to hospitals across Europe, the Middle East, Africa, and Asia-Pacific.
- Ownership category
- akta.pro rank
Neoventa Medical industry classification
Industry- Product category
- Fetal Monitoring Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables) (HLAHACAF)
- akta.pro secondary industries
- Maternal, Neonatal & Pediatric Remote Monitoring (HLACAPAG), Maternal–Fetal & Neonatal Care Pathways (HLACAGAI)
Keywords
Where Neoventa Medical is headquartered
LocationHeadquarters
- HQ city
- Mölndal
- HQ country
- Sweden
- HQ region
- Europe
Offices3 records
Markets served
Neoventa Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Marketing or Sales, Operations, Personnel
Revenue model
- Medical Device Hardware Sales: Sale of Stan S41 Maternal and Fetal Monitors, Goldtrace Fetal Spiral Electrodes, transducers, mounting solutions, and accessories. Hardware products represent the primary revenue stream.
- ST Analysis Software License: ST License activation for Stan S41 monitors enabling fetal ST analysis functionality. License-based recurring revenue model for the proprietary ST analysis feature.
- Education and Training Services: Neoventa Academy provides CTG masterclasses, e-learning courses, online patient case reviews, and certification programs. Training services include 2-day live masterclasses and 1-day online sessions across Europe.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Deep Dive Online Masterclass - Half-day session |
| Other | Pay-as-you-go | CTG Masterclass Rotterdam 2027 - 2-day live course |
| Other | Pay-as-you-go | Masterclass sur le RCF Paris - 2-day course |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Neoventa Medical product offering
Product offeringCore offering
Neoventa Medical develops, manufactures and sells a complete fetal monitoring system built around the Stan S41 maternal and fetal CTG monitor with optional ST analysis of the fetal ECG waveform. The portfolio includes the Goldtrace gold-plated fetal spiral electrode, ST Analysis License software, STAN Viewer review software, and validated integrations with leading central monitoring systems, supported by Neoventa Academy clinical training and certification programs for obstetricians and midwives.
Product overview
Neoventa Medical offers a complete fetal monitoring system centered on the Stan S41 Maternal and Fetal Monitor, a compact device combining CTG (cardiotocography) functionality with optional ST analysis capability. The product portfolio includes the Goldtrace fetal spiral electrode for internal monitoring, ST Analysis License software for advanced ECG waveform analysis, and STAN Viewer desktop software for trace review and education. The STAN Methodology represents the company's integrated approach combining CTG with ST analysis based on 50+ years of research. Additional accessories include mounting solutions, legplate adapters, and the Goldtrace Training Head for skill development. Neoventa also provides comprehensive education services through Neoventa Academy, including masterclasses, e-learning, and patient case reviews.
Differentiator
Problem solved
Functional benefit
Brands
- Stan S41: A compact and highly customizable maternal and fetal CTG monitor with optional ST analysis capability.
- Goldtrace
- Stan Viewer
Products and services
- Stan S41 Maternal and Fetal Monitor Compact maternal and fetal monitor for hospitals and labor wards offering CTG functionality with optional ST analysis of the fetal ECG, wireless waterproof transducers, internal fetal monitoring, and portable mounting options.
- Goldtrace Fetal Spiral Electrode Gold-plated fetal spiral electrode for internal fetal heart rate monitoring during labor, providing signal quality required for both CTG and ST analysis registration.
- Goldtrace Training Head Durable, reusable, latex-free hands-on training device for clinicians to practice fetal spiral electrode application technique.
- ST Analysis License Software license enabling fetal ST analysis functionality on Stan S41 monitors, automatically detecting and alerting changes in the fetal ECG waveform related to anaerobic metabolism during labor.
- STAN Viewer Software Desktop software that lets clinicians access, review, print, and email CTG traces and ST registrations on any standard PC, supporting case discussions, education, and quality assessment with automatic patient de-identification.
- Neoventa Academy Training Programs Professional training and certification programs for obstetricians and midwives covering CTG interpretation, STAN methodology, and fetal monitoring, delivered as live masterclasses, e-learning, and patient case reviews.
Quantifiable outcome
- Reduction in metabolic acidosis at birth demonstrated in clinical practice with established STAN usage
- +1 more outcomes
Companies that use Neoventa Medical
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Neoventa Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration13 records
AI capability2 records
Feature5 records
Neoventa Medical partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered core and minor.
- YMS Medical Supplies (Pty) LTDcoreStrategic alliance formed in November 2023 between Neoventa Medical AB (Sweden) and YMS Medical Supplies (South Africa) to introduce fetal monitoring solutions to the South African market, enhancing maternal and fetal healthcare access in the region.
- IncartacoreDistribution partner covering Australia, New Zealand, Singapore, Malaysia, and Hong Kong markets for Neoventa fetal monitoring products.
- NEXUS / ASTRAIAcoreDistribution and technology integration partner for BeLux (Belgium & Luxembourg), Netherlands, and Germany. Also collaborated on CTG Masterclass Rotterdam 2027 with Erasmus University Medical Center.
- Erasmus University Medical CenterminorAcademic partner collaborating with Neoventa for CTG Masterclass Rotterdam 2027 education program.
- MedexacoreCMS integration partner with full ST data validation for Milou.std and Milou.net Archiving and Surveillance Systems.
- Philips Medical SystemscoreCMS integration partner with validated ST data presentation in IntelliSpace Perinatal for fetal monitoring surveillance.
- CernercoreCMS integration partner with validated ST data presentation in FetaLink (version 200.6 and later) for electronic fetal monitoring integration.
- Huntleigh HealthcarecoreCMS integration partner for Dopplex Centrale and Sonicaid Centrale 3 central monitoring systems with validated ST integration.
- ChipSoft BVcoreCMS integration partner for HiX CS-CTG and EZIS CS-CTG systems with validated ST data presentation.
- K2 Medical SystemscoreCMS integration partner for Guardian System (version 2.005.001 and later) with validated ST data integration.
- Hellmut Habel MedizintechnikcoreDistribution partner for Austria market for Neoventa fetal monitoring products.
- SURGMEDcoreDistribution partner for Canada market for Neoventa fetal monitoring products.
- SpeculumcoreDistribution and CMS integration partner for Portugal market with OmniView-SisPorto validated ST integration.
- Scan-Med a/scoreDistribution partner for Denmark and Norway markets for Neoventa fetal monitoring products.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Neoventa Medical competitors and assessment
Company assessmentBroad incumbents
- Spacelabs Healthcare (OSI Systems): Spacelabs offers fetal/maternal monitoring as part of its broader patient monitoring and connectivity portfolio, competing in the same labor-ward IT category as Neoventa's integrated Stan S41 + CMS solutions. As a broad incumbent, it can bundle fetal monitoring into enterprise-wide monitoring contracts.
- Philips Healthcare (IntelliSpace Perinatal / Avalon FM): Philips offers the Avalon fetal/maternal monitor family and IntelliSpace Perinatal central monitoring system, integrating with Neoventa's ST analysis. As a broad incumbent in patient monitoring, Philips competes in the same labor-ward monitoring category while spanning a much wider product portfolio across a global hospital sales channel.
- Nihon Kohden: Nihon Kohden produces patient monitoring solutions including fetal monitors and central monitoring systems used in obstetric care. It is a broad incumbent with overlapping technology in physiological signal monitoring but covers a wider diagnostic and monitoring portfolio than Neoventa.
- GE Healthcare (Corometrics): GE's Corometrics line is a long-established fetal/maternal monitor franchise sold globally into labor wards. GE competes with Neoventa in the same intrapartum monitoring niche but operates at much broader scale as a diversified medical-imaging and patient-monitoring incumbent.
Direct peers
- Medexa: Medexa provides the Milou central archiving and surveillance system with validated ST integration to Neoventa. It is a direct peer in obstetric central monitoring software and competes for the same hospital IT integrations that complement CTG hardware.
- K2 Medical Systems: K2 Medical Systems produces the Guardian central fetal monitoring system, integrated with Neoventa's ST data, and competes for the same central monitoring platform footprint in labor wards. It is a direct peer in CTG surveillance software with overlapping hospital customer base.
- Huntleigh Healthcare (Sonicaid): Huntleigh's Sonicaid brand is a direct competitor in CTG and Doppler-based fetal monitoring and is also a CMS integration partner of Neoventa. Both companies target the same obstetric departments with comparable hardware and integrate with overlapping central surveillance platforms.
Emerging players
- Edan Instruments: Edan produces the F series of fetal and maternal monitors and competes on price in emerging and mid-tier markets. As an emerging player, Edan addresses similar use cases (CTG during labor) to Neoventa's Stan S41, particularly in markets where Neoventa relies on distributors.
- Contec Medical Systems: Contec manufactures fetal monitors (e.g., F Series and CMS ranges) targeting labor wards, often at lower price points. It is an emerging player offering overlapping CTG-based intrapartum monitoring to similar hospital customers as Neoventa.
- Mindray (F Series Fetal Monitors): Mindray's F Series fetal monitors compete directly with the Stan S41 at the hardware level, offering CTG-focused devices into hospital maternity wards globally. Mindray is an emerging player that has rapidly expanded its presence in maternity monitoring while pricing aggressively versus European specialty vendors like Neoventa.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Neoventa Medical social profiles
Digital presenceNeoventa Medical compliance and trust
Trust signalCompliance4 records
Neoventa Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Neoventa Medical leadership team
Management profileNumber of profiles
Profiles1 record
Neoventa Medical subsidiaries and ownership
Company hierarchySubsidiaries2 records
Neoventa Medical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Neoventa Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Neoventa Medical
What does Neoventa Medical do?
Neoventa Medical develops, manufactures and sells a complete fetal monitoring system built around the Stan S41 maternal and fetal CTG monitor with optional ST analysis of the fetal ECG waveform. The portfolio includes the Goldtrace gold-plated fetal spiral electrode, ST Analysis License software, STAN Viewer review software, and validated integrations with leading central monitoring systems, supported by Neoventa Academy clinical training and certification programs for obstetricians and midwives.
Is Neoventa Medical a public or private company?
Neoventa Medical is a private company. It is classified as unknown and is currently operating.
When was Neoventa Medical founded?
Neoventa Medical was founded in 1997. It employs 11 to 50 people.
Where is Neoventa Medical based?
Neoventa Medical is headquartered in Mölndal, Sweden, in the Europe region.
How does Neoventa Medical make money?
Three revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are ST Analysis Software License and education and Training Services.
Who are Neoventa Medical's main competitors?
Broad incumbents on record are Spacelabs Healthcare (OSI Systems), Philips Healthcare (IntelliSpace Perinatal / Avalon FM), Nihon Kohden and GE Healthcare (Corometrics). Direct peers are Medexa, K2 Medical Systems and Huntleigh Healthcare (Sonicaid). Emerging players are Edan Instruments, Contec Medical Systems and Mindray (F Series Fetal Monitors).
Does Neoventa Medical have an API?
No public API is recorded for Neoventa Medical.
What industry is Neoventa Medical in?
Neoventa Medical's product category is Fetal Monitoring Medical Devices. Its primary akta.pro industry code is HLAHACAF, Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables), with a secondary code of HLACAPAG, Maternal, Neonatal & Pediatric Remote Monitoring. Its NAICS code is 334510 and its SIC code is 3845.